Abstract:Fumihiro Yamaguchi, 1 Ayako Suzuki, 2 Miyuki Hashiguchi, 3 Emiko Kondo, 3 Atsuo Maeda, 4 Takuya Yokoe, 1 Jun Sasaki, 4 Yusuke Shikama, 1 Munetaka Hayashi, 4 Sei Kobayashi, 5 Hiroshi Suzuki 6 1 Department of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan; 2 Department of Pharmacy, Showa University Fujigaoka Hospital, Yokohama, Japan; 3 Department of Infection Control, Showa University Fujigaoka Hospital, Yokohama, Japan; 4 Department of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan; 5 Department of Otolaryngology, Showa University Fujigaoka Hospital, Yokohama, Japan; 6 Department of Cardiology, Showa University Fujigaoka Hospital, Yokohama, Japan Correspondence: Fumihiro Yamaguchi, Department of Respiratory Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, 227-8501, Japan, Email Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), immediately became a pandemic. Therefore, nosocomial infection control is necessary to screen for patients with possible COVID-19. Objective: This study aimed to investigate commonly measured clinical variables to predict COVID-19. Methods: This cross-sectional study enrolled 1087 patients in the isolation ward of a university hospital. Conferences were organized to differentiate COVID-19 from non-COVID-19 cases, and multiple nucleic acid tests were mandatory when COVID-19 could not be excluded. Multivariate logistic regression models were employed to determine the clinical factors associated with COVID-19 at the time of hospitalization. Results: Overall, 352 (32.4%) patients were diagnosed with COVID-19. The majority of the non-COVID-19 cases were predominantly caused by bacterial infections. Multivariate analysis indicated that COVID-19 was significantly associated with age, sex, body mass index, lactate dehydrogenase, C-reactive protein, and malignancy. Conclusion: Some clinical factors are useful to predict patients with COVID-19 among those with symptoms similar to COVID-19. This study suggests that at least two real-time reverse-transcription polymerase chain reactions of SARS-CoV-2 are recommended to exclude COVID-19. Keywords: severe acute respiratory syndrome coronavirus-2, coronavirus disease 2019, nosocomial infection control, nucleic acid test, obesity, cross sectional study, Japan The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) first emerged at the end of 2019. Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 subsequently became a pandemic and remains a burden to humans. Because COVID-19 has no characteristic symptoms, 1,2 nucleic acid or antigen tests to detect the N gene or N protein of SARS-CoV-2 are necessary for the diagnosis; however, false-negative results are a critical medical problem. 3,4 In November 2020, we experienced a large cluster of COVID-19 in our institute because a few patients with COVID-19 were missed. At that time, a single nucleic acid test was used to determine whether a patient had COVID-19. Thereafter, significant changes in nosocomial infection control of COVID-19 were established in our institute. More specifically, we organized conferences of respiratory physicians to differentiate COVID-19 from non-COVID-19 cases and decided to transfer patients without COVID-19 from the isolation ward to the general ward. In addition, multiple nucleic acid tests should be performed if COVID-19 could not be excluded based on physical and imaging findings even if a nucleic acid test was negative. This strategy may be effective in future pandemic events. It is necessary to screen patients with possible COVID-19 for nosocomial infection control. Previous studies have mostly focused on mortality-related factors of COVID-19. 5–9 However, only a few studies have analyzed the risk of COVID-19. Since November 2021, omicron variants have been reported worldwide, and there is growing concern about its infectivity, transmissibility, and antigenicity. 10,11 Most notably, BA.5, an omicron variant that has been endemic in Japan since July 2022, has a predominance of increased infection and immune escape, compared with previous lineages. 12 Meanwhile, the previous lineages had a higher rate of severe illness and mortality than BA.5, making it crucial to prevent horizontal nosocomial transmission by strict isolation. In this study, we aimed to investigate the efficacy of clinical factors to predict patients with COVID-19 in the isolation ward befor -Abstract Truncated-

Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and omicron variants in tertiary hospitals of Japan

Comparison of SARS-CoV-2 Delta- and Omicron-Dominant Periods

Association between regional critical care capacity and the incidence of invasive mechanical ventilation for coronavirus disease 2019: a population-based cohort study

Increased national critical care demands were associated with a higher mortality of intubated COVID-19 patients in Japan: a retrospective observational study

Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study

重症COVID–19におけるデルタ株流行の影響と予後：単施設後方視研究(Prognostic impact of delta variant in COVID–19 patients requiring mechanical ventilation in comparison with other variants: a single center retrospective analysis)

Combination of rRT-PCR and Clinical Features to Predict Coronavirus Disease 2019 for Nosocomial Infection Control

Comparison of the treatment status of patients with acute heart failure before and during the COVID-19 pandemic – Observational cohort study using Japanese administrative data

Differential Characteristics of Patients for Hospitalized Severe COVID-19 Infected by the Omicron Variants and Wild Type of SARS-CoV-2 in China

Impact of the COVID-19 pandemic on management and outcomes of patients with acute heart failure

90-day outcomes in patients with severe COVID-19 pneumonia treated with invasive mechanical ventilation.

Clinical characteristics and risk factors of non-mild outcomes in patients with Omicron variant COVID-19 in Shanghai, China

Factors associated with difficulty in hospital acceptance during the COVID-19 pandemic period in Osaka Prefecture, Japan: a population-based study

Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan

Severity of SARS-CoV-2 infection in pregnant women and their neonates during the Omicron period compared to the pre-Omicron period: A retrospective cohort study

Clinical outcomes after tracheostomy in patients with coronavirus disease 2019: a single-center experience in Japan

Post-Coronavirus Disease 2019 Syndrome in Japan: An Observational Study Using a Medical Database

Predictors of disease severity in SARS‐CoV‐2 omicron variant XBB sublineages and variants of interest

Clinical and survival differences during separate COVID-19 surges: Investigating the impact of the Sars-CoV-2 alpha variant in critical care patients.

Clinical characteristics and high risk factors of patients with Omicron variant strain infection in Hebei, China

Maintaining health-system functionality in response to the surge of COVID-19 cases due to the Omicron variant, Japan